Dennis Mulroy is CFO at LA JOLLA PHARMACEUTICAL CO (LJPC). They have made 7 open-market trades across 2 companies since 2017, most recently 2026-01-08.
CIK 0001276840
1 open-market purchase totalling $17K since 2017, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANAB | 21,852 | $1.0M |
| LJPC | 5,067 | $32K |
| Total | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-01-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAB | SELL | 2026-01-08 | 2026-01-09 | $44.71 | $112K | +6.3% | +12.1% | +53.9% |
| ANAB | SELL | 2026-01-07 | 2026-01-08 | $45.11 | $86K | +9.2% | +16.8% | +53.3% |
| ANAB | SELL | 2026-01-05 | 2026-01-06 | $43.26 | $145K | +0.1% | +4.9% | +36.8% |
| ANAB | SELL · 10b5-1 | 2025-12-22 | 2025-12-23 | $50.00 | $500K | -12.2% | -5.3% | +25.4% |
| ANAB | SELL · 10b5-1 | 2025-12-16 | 2025-12-18 | $44.86 | $1.4M | +1.8% | -2.9% | +35.9% |
| ANAB | SELL · 10b5-1 | 2024-09-16 | 2024-09-17 | $39.76 | $574K | -15.0% | -6.2% | -55.6% |
| ANAB | SELL · 10b5-1 | 2024-05-22 | 2024-05-24 | $23.72 | $36K | -0.3% | +0.3% | +55.5% |
| ANAB | SELL | 2024-01-30 | 2024-02-01 | $23.63 | $145K | -8.1% | +9.2% | +8.7% |
| ANAB | SELL | 2024-01-08 | 2024-01-09 | $21.81 | $48K | +3.9% | +1.2% | -9.5% |
| ANAB | SELL | 2023-09-14 | 2023-09-18 | $19.35 | $192K | -6.1% | -3.5% | +2.5% |
| LJPC | BUY | 2017-03-03 | 2017-03-06 | $33.95 | $17K | +1.9% | -17.4% | -14.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.